Impact of meditation, support groups seen at cellular level in breast cancer survivors
11/05/2014
For the first time, researchers have shown that practising mindfulness meditation or being involved in a support group has a positive physical impact at the cellular level in breast cancer survivors.
Can Tai Chi reduce inflammation for breast cancer survivors?
11/05/2014
Tai Chi has been linked with numerous health benefits. Now, a UCLA study claims that the Chinese martial art reduces inflammation among breast cancer survivors with insomnia.
Combination treatment for metastatic melanoma results in longer overall survival
11/04/2014
Among patients with metastatic melanoma, treatment with a combination of the drugs sargramostim plus ipilimumab, compared with ipilimumab alone, resulted in longer overall survival and lower...
NSAIDs induce 'suicide' in potentially cancerous intestinal cells
11/04/2014
A new study finally explains the mechanism behind the protective effects of NSAIDs against colorectal cancer. The drugs cause cells carrying a gene mutation to initiate suicide.
Onxeo S.A., an innovative biopharmaceutical company specializing in the development of orphan oncology drugs, has announced positive preliminary top-line results from its Phase II clinical trial of...
Vanderbilt-led study investigates potential postpartum breast cancer therapy
11/04/2014
Nearly 25 percent of all breast cancers among premenopausal women occur within two to five years following a pregnancy.
First detailed picture of a cancer-related cell enzyme in action on a chromosome unit
11/04/2014
A landmark study published in the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast cancer protein.
New classification improves risk prediction in chronic lymphocytic leukemia
11/04/2014
If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic...
Pharming Group NV and Salix Pharmaceuticals, Ltd. has announced the launch of RUCONEST® (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg in the United States for the treatment of acute angioedema...
How migratory cancer cells acquire 'stem-like' properties
11/04/2014
In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic.